Skip to main content

Advertisement

Log in

Reply to: CT and PET/CT Surveillance in Stage IIIA-D Melanoma Results in More False-Positive Than True-Positive Findings and Should Not be Routinely Recommended, by Nicholas Taylor et al.

  • Melanoma
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Taylor NA, Brodland DG. CT and PET-CT surveillance in stages 3A to 3D melanoma results in more false-positive than true-positive findings and should not be routinely recommended. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-09820-3.

    Article  PubMed  Google Scholar 

  2. Turner RM, Dieng M, Khanna N, et al. Performance of long-term CT and PET/CT surveillance for detection of distant recurrence in patients with resected stage IIIA–D melanoma. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-020-09270-3.

    Article  PubMed  Google Scholar 

  3. Nijhuis AAG, Dieng M, Khanna N, Lord SJ, Dalton J, Menzies AM, et al. False-positive results and incidental findings with annual CT or PET/CT surveillance in asymptomatic patients with resected stage III melanoma. Ann Surg Oncol. 2019;26:1860–8.

    Article  Google Scholar 

  4. Martin A, Einstein A, Saw RPM, Thompson JF, Emmet L, Nieweg O, Morton RL. Radiation risk from computed tomography surveillance imaging in asymptomatic adults treated for stage III Melanoma: a simulation modelling study. In: Abstract presented at the 9th World Congress of Melanoma, Brisbane, 18–21 October 2017.

  5. Mettler FA, Huda W, Yoshizumi TT, Mahesh M. Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology. 2008;248:254–63. https://doi.org/10.1148/radiol.2481071451.

    Article  PubMed  Google Scholar 

  6. Holtkamp LHJ, Read RL, Emmett L, Thompson JF, Nieweg OE. Futility of imaging to stage melanoma patients with a positive sentinel lymph node. Melanoma Res. 2017;27:457–62.

    Article  Google Scholar 

  7. Aukema TS, Valdés Olmos RA, Wouters MWJM, Klop WMC, Kroon BBR, Vogel WV, Nieweg OE. Utility of preoperative 18F-FDG PET/CT and brain MRI in melanoma patients with palpable lymph node metastases. Ann Surg Oncol. 2010;17:2773–8.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mbathio Dieng PhD.

Ethics declarations

Disclosures

John F. Thompson is the recipient of an NHMRC Program Grant (No. 1093017). He has received honoraria for advisory board participation from BMS Australia, MSD Australia, GSK, and Provectus Inc, and travel support from GSK and Provectus Inc. Robyn P. M. Saw served on the - Advisory Board for Novartis, MSD, and Qbiotics and received speaking honoraria from BMS. Andrew Einstein reported receiving grant funding to Columbia University for unrelated research from the National Heart Lung, and Blood Institute, the National Cancer Institute, the International Atomic Energy Agency, Canon Medical Systems, GE Healthcare, Roche Diagnostics, and W. L. Gore & Associates and consulting and lecturing fees from Ionetix and W. L. Gore & Associates.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dieng, M., Lord, S.J., Nieweg, O.E. et al. Reply to: CT and PET/CT Surveillance in Stage IIIA-D Melanoma Results in More False-Positive Than True-Positive Findings and Should Not be Routinely Recommended, by Nicholas Taylor et al.. Ann Surg Oncol 28 (Suppl 3), 819–820 (2021). https://doi.org/10.1245/s10434-021-09821-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-09821-2

Navigation